SCHEMBL6232087

SCHEMBL6232087

CC(C)(C)c1c(F)ccc(O)c1O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.37
ALOX15 P16050 3/20 0.37
HSD17B10 Q99714 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
HPGD P15428 1/20 0.37
LMNA P02545 2/20 0.35
TYR P14679 2/20 0.35
NR1I2 O75469 1/20 0.35
CYP2C9 P11712 1/20 0.35
MIF P14174 1/20 0.35
HTT P42858 1/20 0.35
NFE2L2 Q16236 1/20 0.35
PTGS1 P23219 1/20 0.35
PTGS2 P35354 1/20 0.35
CA3 P07451 1/20 0.34
CA6 P23280 1/20 0.34
CA5A P35218 1/20 0.34
CA9 Q16790 1/20 0.34
CA14 Q9ULX7 1/20 0.34
CA5B Q9Y2D0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17030735 0.86 TYR (0.39) ALDH1A1ALOX15HSD17B10TDP1HPGD
SCHEMBL8819969 0.80 ALDH1A1 (0.42) ALDH1A1ALOX15HSD17B10TDP1HPGD
SCHEMBL19695748 0.80 ATM (0.38) ALDH1A1ALOX15HSD17B10TDP1HPGD
SCHEMBL2778277 0.78 ALDH1A1 (0.34) ALDH1A1ALOX15HSD17B10TDP1HPGD
SCHEMBL19104225 0.78 DPP4 (0.33) ALDH1A1HSD17B10TDP1CYP2C9HTT
SCHEMBL17030737 0.77 ALDH1A1 (0.37) ALDH1A1ALOX15HSD17B10TDP1HPGD
SCHEMBL1053673 0.74 ESR1 (0.41) ALDH1A1ALOX15HSD17B10TDP1HPGD
SCHEMBL50519 0.74 ALDH1A1 (0.46) ALDH1A1ALOX15HSD17B10TDP1HPGD
SCHEMBL30041549 0.74 ALDH1A1 (0.46) ALDH1A1ALOX15HSD17B10TDP1HPGD
SCHEMBL24945815 0.74 DAO (0.35) ALDH1A1ALOX15HSD17B10TDP1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP claimed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO claimed
US-11040987-B2 Penam derivatives for treating bacterial infections TENNOR THERAPEUTICS LIMITED (CN) 2021-06-22 US disclosed
US-20210070774-A1 PENAM DERIVATIVES FOR TREATING BACTERIAL INFECTIONS TENNOR THERAPEUTICS LIMITED (CN) 2021-03-11 US disclosed
US-20160346270-A1 BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2 AUSPEX PHARMACEUTICALS, INC. 2016-12-01 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210070774-A1 PENAM DERIVATIVES FOR TREATING BACTERIAL INFECTIONS BPGM, BLVRB, PREP ALDH1A1 1966/4885ALOX15 1635/4885HSD17B10 3493/4885
US-11040987-B2 Penam derivatives for treating bacterial infections BPGM, BLVRB, PREP ALDH1A1 1966/4885ALOX15 1635/4885HSD17B10 3493/4885
US-20160346270-A1 BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2 SLC18A2, SLC6A2, SLC18A1 ALDH1A1 538/4885ALOX15 2394/4885HSD17B10 625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.